Home>>Signaling Pathways>> Proteases>> Endogenous Metabolite>>7-Ketolithocholic acid

7-Ketolithocholic acid Sale

(Synonyms: 3Α-羟基-7-氧代-5Β-胆烷酸,3α-Hydroxy-7-oxo-5β-cholanic acid) 目录号 : GC39474

7-Ketolithocholic acid (3α-hydroxy-7-oxygen-5β-cholic acid)是一种胆汁酸,7-Ketolithocholic acid可被吸收,7-ketolithocholic acid抑制内源性胆汁酸的产生,并可影响分泌胆汁胆固醇。

7-Ketolithocholic acid Chemical Structure

Cas No.:4651-67-6

规格 价格 库存 购买数量
500mg
¥350.00
现货

电话:400-920-5774 Email: sales@glpbio.cn

Customer Reviews

Based on customer reviews.

Sample solution is provided at 25 µL, 10mM.

Description

7-Ketolithocholic acid (3α-hydroxy-7-oxygen-5β-cholic acid) is a kind of bile acid, 7-Ketolithocholic acid can be absorbed, 7-ketolithocholic acid inhibits the production of endogenous bile acid, and can affect the secretion of biliary cholesterol[1,2].

After 7-ketolithocholic acid (400 mg/day) was administered orally for 14 days, biliary bile acid composition changed: The proportion of cholic acid decreased (from 45% to 19%), deoxycholic acid decreased (from 15% to 10%), chenodeoxycholic acid increased markedly (from 36% to 59%), ursodeoxycholic acid increased (from 36% to 59%), ursodeoxycholic acid increased (from 2% to 7%), and lithocholic acid increased (from 2% to 5%), while only trace amounts of 7-ketolithocholic acid were detected. During this treatment, the biliary lithogenic index fell from 2.6 to 0.9 and was accompanied by a pronounced drop in biliary cholesterol concentration[2].

References:
[1]. Choucair I, Nemet I, et,al. Quantification of bile acids: a mass spectrometry platform for studying gut microbe connection to metabolic diseases. J Lipid Res. 2020 Feb;61(2):159-177. doi: 10.1194/jlr.RA119000311. Epub 2019 Dec 9. PMID: 31818878; PMCID: PMC6997600.
[2]. Salen G, Verga D, et,al. Effect of 7-ketolithocholic acid on bile acid metabolism in humans. Gastroenterology. 1982 Aug;83(2):341-7. PMID: 7084613.

7-Ketolithocholic acid (3α-hydroxy-7-oxygen-5β-cholic acid)是一种胆汁酸,7-Ketolithocholic acid可被人体吸收,7-ketolithocholic acid抑制内源性胆汁酸的产生,可影响胆汁胆固醇的分泌[1,2]

口服 7-酮石胆酸(400 毫克/天)14 天后,胆汁酸成分发生变化:胆酸比例下降(从 45% 下降到 19%),脱氧胆酸下降(从 15% 下降到10%),鹅去氧胆酸显着增加(从 36% 到 59%),熊去氧胆酸增加(从 36% 到 59%),熊去氧胆酸增加(从 2% 到 7%),石胆酸增加(从 2% 到5%), 而仅检测到痕量的 7-酮石胆酸。在此治疗期间,胆道结石指数从 2.6 降至 0.9,并伴随着胆道胆固醇浓度的显着下降[2]

实验参考方法

Clinical experiment [1]:

Animal models

5 male subjects with gallstones (mean age, 55 years old)

Preparation Method

400 mg/day of uniformly labeled 7-ketolithocholic acid (sp act, 1000 * 100 dpm/mg) was fed to each patient daily for 2 wk and the specific activities of chenodeoxycholic acid and ursodeoxycholic acid in bile were measured every other day.

Dosage form

400 mg/day for 2 week Intravenous injection.

Applications

7-ketolithocholic acid is absorbed, and suppresses endogenous bile acid production and biliary cholesterol secretion.

References:

[1]. Salen G, Verga D, et,al. Effect of 7-ketolithocholic acid on bile acid metabolism in humans. Gastroenterology. 1982 Aug;83(2):341-7. PMID: 7084613.

化学性质

Cas No. 4651-67-6 SDF
别名 3Α-羟基-7-氧代-5Β-胆烷酸,3α-Hydroxy-7-oxo-5β-cholanic acid
Canonical SMILES C[C@H](CCC(O)=O)[C@H]1CC[C@@]2([H])[C@]3([H])C(C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)=O
分子式 C24H38O4 分子量 390.56
溶解度 DMF: 30 mg/ml,DMSO: 30 mg/ml,Ethanol: 30 mg/ml,Ethanol:PBS (pH 7.2) (1:3): 0.25 mg/ml 储存条件 Store at -20°C
General tips 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。
Shipping Condition 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。

溶解性数据

制备储备液
1 mg 5 mg 10 mg
1 mM 2.5604 mL 12.8021 mL 25.6043 mL
5 mM 0.5121 mL 2.5604 mL 5.1209 mL
10 mM 0.256 mL 1.2802 mL 2.5604 mL
  • 摩尔浓度计算器

  • 稀释计算器

  • 分子量计算器

质量
=
浓度
x
体积
x
分子量
 
 
 
*在配置溶液时,请务必参考产品标签上、MSDS / COA(可在Glpbio的产品页面获得)批次特异的分子量使用本工具。

计算

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % saline
计算重置

产品文档

Quality Control & SDS

View current batch: